NCT05977322
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05977322
Title A Phase I Study of [177Lu]Lu-FF58 in Patients With Advanced Solid Tumors.
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors Novartis Pharmaceuticals
Indications
Therapies
Age Groups: adult | senior
Covered Countries NLD | ISR | ESP | CHE

Facility Status City State Zip Country Details
Novartis Investigative Site Tel Aviv 6423906 Israel Details
Novartis Investigative Site Nijmegen 6500HB Netherlands Details
Novartis Investigative Site L'Hospitalet de Llobregat Catalonia 08907 Spain Details
Novartis Investigative Site Madrid 28034 Spain Details
Novartis Investigative Site Geneva CH 1211 Switzerland Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field